Literature DB >> 26388231

The Alzheimer disease market.

XiaoXiao Qian1, Bashar Hamad1, Gus Dias-Lalcaca1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26388231     DOI： 10.1038/nrd4749

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  2015 Alzheimer's disease facts and figures.

Authors: 
Journal:  Alzheimers Dement       Date:  2015-03       Impact factor: 21.566
  1 in total
  12 in total

Review 1.  Critical role of mitosis in spontaneous late-onset Alzheimer's disease; from a Shugoshin 1 cohesinopathy mouse model.

Authors:  Chinthalapally V Rao; Mudassir Farooqui; Adam S Asch; Hiroshi Y Yamada
Journal:  Cell Cycle       Date:  2018-09-20       Impact factor: 4.534

2.  Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer's Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist.

Authors:  Kai Lun Chang; Ling Rong Wong; Hai Ning Pee; Shili Yang; Paul Chi-Lui Ho
Journal:  Mol Neurobiol       Date:  2019-04-23       Impact factor: 5.590

Review 3.  Ion channel regulation by β-secretase BACE1 - enzymatic and non-enzymatic effects beyond Alzheimer's disease.

Authors:  Sandra Lehnert; Stephanie Hartmann; Sabine Hessler; Helmuth Adelsberger; Tobias Huth; Christian Alzheimer
Journal:  Channels (Austin)       Date:  2016-06-02       Impact factor: 2.581

4.  Effective Theranostic Cyanine for Imaging of Amyloid Species in Vivo and Cognitive Improvements in Mouse Model.

Authors:  Yinhui Li; Chen Chen; Di Xu; Chung-Yan Poon; See-Lok Ho; Rui Zheng; Qiong Liu; Guoli Song; Hung-Wing Li; Man Shing Wong
Journal:  ACS Omega       Date:  2018-06-25

5.  Contribution of syndecans to cellular internalization and fibrillation of amyloid-β(1-42).

Authors:  Tamás Letoha; Anett Hudák; Erzsébet Kusz; Aladár Pettkó-Szandtner; Ildikó Domonkos; Katalin Jósvay; Martin Hofmann-Apitius; László Szilák
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

Review 6.  History and progress of hypotheses and clinical trials for Alzheimer's disease.

Authors:  Pei-Pei Liu; Yi Xie; Xiao-Yan Meng; Jian-Sheng Kang
Journal:  Signal Transduct Target Ther       Date:  2019-08-23

7.  High-affinity Anticalins with aggregation-blocking activity directed against the Alzheimer β-amyloid peptide.

Authors:  Sabine Rauth; Dominik Hinz; Michael Börger; Markus Uhrig; Manuel Mayhaus; Matthias Riemenschneider; Arne Skerra
Journal:  Biochem J       Date:  2016-03-30       Impact factor: 3.857

8.  UB-311, a novel UBITh® amyloid β peptide vaccine for mild Alzheimer's disease.

Authors:  Chang Yi Wang; Pei-Ning Wang; Ming-Jang Chiu; Connie L Finstad; Feng Lin; Shugene Lynn; Yuan-Hung Tai; Xin De Fang; Kesheng Zhao; Chung-Ho Hung; Yiting Tseng; Wen-Jiun Peng; Jason Wang; Chih-Chieh Yu; Be-Sheng Kuo; Paul A Frohna
Journal:  Alzheimers Dement (N Y)       Date:  2017-04-14

Review 9.  Imaging Alzheimer's disease pathophysiology with PET.

Authors:  Lucas Porcello Schilling; Eduardo R Zimmer; Monica Shin; Antoine Leuzy; Tharick A Pascoal; Andréa L Benedet; Wyllians Vendramini Borelli; André Palmini; Serge Gauthier; Pedro Rosa-Neto
Journal:  Dement Neuropsychol       Date:  2016 Apr-Jun

10.  Contribution of syndecans to cellular uptake and fibrillation of α-synuclein and tau.

Authors:  Anett Hudák; Erzsébet Kusz; Ildikó Domonkos; Katalin Jósvay; Alpha Tom Kodamullil; László Szilák; Martin Hofmann-Apitius; Tamás Letoha
Journal:  Sci Rep       Date:  2019-11-12       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.